To pool the data, the relevant cohort investigators provided the following individual participant data: age, sex, height, weight, and other confounders such as smoking status and alcohol consumption at baseline as well as breast cancer incidence during the follow-up period. The ACC’s ...
Among those with no ICD-10 diagnosis at T0, 8.2% were positive for affective disorders at the 6-month follow-up. Conclusions: This study suggested that SEGT is effective for breast cancer patients with affective disorders, and indicates the need for prospective evaluations in order to identify ...
Multivariable hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using Cox proportional hazards models, adjusted for other breast cancer risk factors. Results After a median follow-up of 8.1 years, 13,241 breast cancer cases occurred. In the multivariable-adjusted model, ...
In total, 6573 deaths occurred during follow-up, of which 2313 (35.2%) were owing to breast cancer. Five-year survival was 91.1% (OS) and 96.3% (BCSS), while 10-year survival was 79.5% (OS) and 93.1% (BCSS). In the unadjusted analysis, Mx-RT was associated with the lowest OS ...
Objectives:Little is known about cancer prevalence due to a lack of systematic recording of cancer patient follow-up data. To estimate the annual hospital prevalence of breast cancer in the general population of the Isère department (1.1 million inhabitants) in the Rhne-Alpes region, the second...
Applicable CPT / HCPCS / ICD-10 Codes Background References Policy Scope of Policy This Clinical Policy Bulletin addresses breast and ovarian cancer susceptibility gene testing, prophylactic mastectomy, and prophylactic oophorectomy. Medical Necessity Prophylactic Mastectomy Aetna considers prophylactic mastecto...
This study has been approved by the privacy committee of The Netherlands Cancer Registry. Patients All women diagnosed with primary invasive stage I-IIIA breast cancer in 2003, treated with BCS with RT, of whom the start date of RT was known and follow-up was complete, were included. ...
Also, UpToDate reviews on “Principles of grafts and flaps for reconstructive surgery” (Morris, 2013) and “Breast reconstruction in women with breast cancer” (Nahabedian, 2013) do not mention the body lift perforator flap technique as a management tool for breast reconstruction....
Local recurrence rates were 0.9 % for invasive breast cancer and 3 % for DCIS after mean follow-up of 33 months. There was no evidence of a learning curve. The authors concluded that RSL is a safe, effective procedure that is easy to learn, with a low incidence of positive/close ...
Long-term follow-up of the randomized Stockholm trial on adjuvant tamoxifen among postmenopausal patients with early stage breast cancer. Acta Oncol. 2007;46(2):133-145. doi:10.1080/02841860601034834PubMedGoogle ScholarCrossref 7. Swerdlow AJ, Jones ME; British Tamoxifen Second ...